Apple Stock Eyes Upside as Courts and Regulators Blink

Apple ( (AAPL) ) has been popular among investors this week. Here is a recap of the key news on this stock.

Apple is navigating two major regulatory and legal fronts with potentially important implications for its stock. In the U.S., the company won a key procedural victory after a federal judge refused to grant Masimo’s request to block imports of the Apple Watch Series 9 and Ultra 2. The decision allows Apple to keep selling and importing these high-margin wearables while a patent dispute over blood-oxygen sensing technology continues. Apple has already pushed a software redesign that shifts some blood-oxygen processing to the iPhone, arguing it complies with U.S. Customs guidance, though Masimo disputes that this fixes the alleged infringement. For investors, the ruling removes an immediate overhang on Apple Watch revenue, even if legal uncertainty persists in the background.

In Brazil, Apple agreed to open its iOS ecosystem in a way that could reshape its services business in one of Latin America’s largest markets. To settle a long-running antitrust case brought by regulator CADE after a complaint from e-commerce giant MercadoLibre, Apple will allow third-party app stores, outside payment methods for in-app purchases, and links to external websites for transactions. The changes must be implemented within 105 days and will stay in force for three years, with potential fines of up to 150 million reais for non-compliance. While Apple warns the move could increase security and privacy risks, the settlement underscores growing global pressure on its App Store model and fee structure. Despite these challenges, Wall Street remains broadly constructive: AAPL carries a Moderate Buy consensus, with analysts’ average price target around $299 per share, implying roughly 9–10% upside from current levels.